SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-045545
Filing Date
2022-04-13
Accepted
2022-04-13 17:07:06
Documents
4
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223475-1_def14a.htm DEF 14A 670981
2 GRAPHIC lg_protagonist-pn.jpg GRAPHIC 42508
3 GRAPHIC tm223475d1-px_01pagebw.jpg GRAPHIC 519088
4 GRAPHIC tm223475d1-px_02pagebw.jpg GRAPHIC 469162
  Complete submission text file 0001104659-22-045545.txt   2090880
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 22825301
SIC: 2834 Pharmaceutical Preparations